Kestra Investment Management, LLC
Source: SEC Form 13F · as of Mar 2026Kestra Investment Management, LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $36.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$36.0M
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 29,185 | $4.8M |
| JNJJOHNSON & JOHNSON | 18,357 | $4.5M |
| PFEPFIZER INC | 101,867 | $2.9M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 8,396 | $2.8M |
| LLYELI LILLY & Co | 2,901 | $2.7M |
| ABBVAbbVie Inc. | 11,136 | $2.4M |
| MRKMerck & Co., Inc. | 18,594 | $2.2M |
| CORCencora Inc. | 6,664 | $2.1M |
| GILDGILEAD SCIENCES, INC. | 13,936 | $1.9M |
| CAHCardinal Health Inc. | 8,613 | $1.8M |
| AMGNAMGEN INC | 4,452 | $1.6M |
| BMYBRISTOL MYERS SQUIBB CO | 18,187 | $1.1M |
| MEDPMedpace Holdings Inc. | 1,914 | $919K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,286 | $889K |
| INCYIncyte Corp. | 8,428 | $793K |
| RPRXRoyalty Pharma plc | 12,318 | $591K |
| PRGOPERRIGO Co plc | 51,157 | $549K |
| GMOptec International, Inc. | 5,897 | $439K |
| NVSNovartis AG | 1,690 | $258K |
| ABTABBOTT LABORATORIES | 2,348 | $241K |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 460 | $241K |
| SNYSanofi | 4,993 | $241K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.